HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Carter-Wallace

This article was originally published in The Rose Sheet

Executive Summary

Sale of consumer products division to Church & Dwight will close by end of September after shareholders approved transaction Sept. 21, firm says. Church & Dwight announced it would purchase Carter-Wallace division in May, noting addition of brands such as Arrid antiperspirants and deodorants, Trojan condoms and First Response pregnancy tests will triple company's personal care sales to $500 mil. (1"The Rose Sheet" May 14, p. 9). Group of health care executives known as MedPointe Capital Partners will purchase health care business and rights to Carter-Wallace name

You may also be interested in...



Church & Dwight U.S. Personal Care Sales Near $500 Mil. With C-W Brands

Church & Dwight's U.S. personal care product sales will increase more than three-fold to nearly $500 mil. with the acquisition of the Carter-Wallace consumer brands. Revenues for Church & Dwight's personal products business currently total about $150 mil., according to the company.

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Beauty Claims Inch Closer To Pharma As Cosmeceutical Sector Expands

Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle

Latest Headlines
See All
UsernamePublicRestriction

Register

RS009636

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel